BioValley News

21.01.2014

Basel based 4-Antibody sold to Agenus

Boston based Agenus announced to acquire all of the outstanding stocks of 4-Antibody. The initial payment of $10...[more]


21.01.2014

Roche is back in the field of RNA based therapeutics

Three years ago, Roche stepped out of RNA based therapeutics research, a field that has once been believed to be a game...[more]


11.12.2013

University of Pennsylvania and Novartis present groundbreaking results at ASH

A few months ago Novartis announced to invest 20 million dollars to license a gene therapy technology from the...[more]


11.12.2013

Roche and Molecular Partners close a 1 billion dollar deal

Roche, which has with Kadcyla one of the most advanced anti-body drug conjugates on the market, has entered a...[more]


International News

20.10.2014

Study shows medication is frequently, unintentionally given incorrectly to young children

(Nationwide Children's Hospital) According to Nationwide Children's Hospital researchers, 63,000 children under the age of six experienced out-of-hospital medication errors annually between 2002 and 2012. One child is affected every eight minutes, usually by a well-meaning parent or caregiver unintentionally committing a medication error.


20.10.2014

Mummy remains refute antiquity of ankylosing spondylitis

(Wiley) Ankylosing spondylitis is a systemic disease that causes inflammation in the spinal joints and was thought to have affected members of the ancient Egyptian royal families. Now a new study published in Arthritis & Rheumatology, a journal of the American College of Rheumatology, refutes that claim, finding instead a degenerative spinal condition called diffuse idiopathic skeletal hyperostosis in royal Egyptian mummies from the 18th to early 20th Dynasties.


20.10.2014

Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025

(Alzheimer's Association) A workgroup of nearly 40 Alzheimer's researchers and scientists says the research milestones in the US Government's National Plan to Address Alzheimer's Disease must be broadened in scope, increased in scale, and adequately funded in order to successfully achieve this goal. A series of proposals by the workgroup to enlarge and strengthen the Plan are published today in Alzheimer's & Dementia: the Journal of the Alzheimer's Association.


About BioValley Basel

BioValley Basel is a Non-Profit organisation. It is the Swiss pillar of the trinational BioValley Initiative.

BioValley Basel aims at:

  • FOSTER a networking and integration platform amongst the Life Sciences Community in the Basel Region
  • ENABLE and FACILITATE an open network, beyond political and geographical boundaries
  • MODERATE and SUPPORT networking activities for the regional Life Sciences Community

Read more

Useful Links / Infos

Please find many interesting information and links in this section:

Job Market

Office Spaces

Databases

  • Company Database
  • Enterprise Europe Network Database

Living in Basel

  • Restaurants & Bars
  • Hotel Guide
  • Housing Market

Partner